These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18473966)

  • 1. Towards a gene therapy clinical trial for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy approaches for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Mavilio F; De Luca M
    Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
    Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
    Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy for Epidermolysis Bullosa.
    Marinkovich MP; Tang JY
    J Invest Dermatol; 2019 Jun; 139(6):1221-1226. PubMed ID: 31068252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
    Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
    Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of skin adhesion disorders (mini review).
    Cavazza A; Mavilio F
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1868-76. PubMed ID: 22250710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
    Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
    Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa.
    De Rosa L; Secone Seconetti A; De Santis G; Pellacani G; Hirsch T; Rothoeft T; Teig N; Pellegrini G; Bauer JW; De Luca M
    Cell Rep; 2019 May; 27(7):2036-2049.e6. PubMed ID: 31091444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
    Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
    Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
    Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
    Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of inherited skin adhesion disorders: a critical overview.
    De Luca M; Pellegrini G; Mavilio F
    Br J Dermatol; 2009 Jul; 161(1):19-24. PubMed ID: 19466960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy.
    Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E
    Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
    Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
    J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.
    Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA
    J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
    Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
    N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo gene therapy cures a blistering skin disease.
    Featherstone C; Uitto J
    Trends Mol Med; 2007 Jun; 13(6):219-22. PubMed ID: 17416553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.